Morgan Stanley’s Nuvectis Pharma NVCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$184K Buy
2025
Q1
$68.2K Buy
2024
Q4
$12.5K Sell
2024
Q3
$14.8K Sell
2024
Q2
$64.6K Sell
2024
Q1
$338K Sell
2023
Q4
$382K Buy
2023
Q3
$44.8K Sell
2023
Q2
$81.5K Buy
2023
Q1
$40.8K Buy
2022
Q4
$2.26K Buy
2022
Q3
$1K Buy
2022
Q2
$2K Buy